Home›Companies›Biotech & Pharma›FORAY bioscience

FORAY bioscience, Inc.

Updated Oct 27, 2026·Latest SEC filing Mar 14, 2024·Suggest an edit

About FORAY bioscience

FORAY bioscience is a private company based in Cambridge, Massachusetts, incorporated in 2022 in Delaware. It has reported $3,413,246 raised in one offering on Form D since March 2024. Its chief executive is Ashley Beckwith.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 28, 2024Mar 14, 2024$3,413,246of $3.9M target10$341KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on FORAY bioscience's Form D filed Mar 14, 2024.

AB
Ashley Beckwith
Chief Executive Officer and director

Sources

  1. SECFORAY bioscience, Inc. filing history